Literature DB >> 31620481

A revealing review of mesenchymal stem cells therapy, clinical perspectives and Modification strategies.

Pardis Saeedi1, Raheleh Halabian1, Abbas Ali Imani Fooladi1.   

Abstract

Multipotent mesenchymal stem cells (MSCs) have been considerably inspected as effective tool for cell-based therapy of inflammatory, immune-mediated, and degenerative diseases, attributed to their immunomodulatory, immunosuppressive, and regenerative potentials. In the present review, we focus on recent research findings of the clinical applications and therapeutic potential of this cell type, MSCs' mechanisms of therapy, strategies to improve their therapeutic potentials such as manipulations and preconditioning, and potential/unexpected risks which should be considered as a prerequisite step before clinical use. The potential risks would probably include undesirable immune responses, tumor formation and the transmission of incidental agents. Then, we also review some of the milestones in the field, briefly discuss challenges and highlight the new guideline suggested for future directions and perspectives. 2019 Stem Cell Investigation. All rights reserved.

Entities:  

Keywords:  Mesenchymal stem cells (MSCs); genetic manipulation; potential risks; preconditioning

Year:  2019        PMID: 31620481      PMCID: PMC6789202          DOI: 10.21037/sci.2019.08.11

Source DB:  PubMed          Journal:  Stem Cell Investig        ISSN: 2306-9759


  58 in total

Review 1.  Mesenchymal stem cells: a new trend for cell therapy.

Authors:  Xin Wei; Xue Yang; Zhi-peng Han; Fang-fang Qu; Li Shao; Yu-fang Shi
Journal:  Acta Pharmacol Sin       Date:  2013-06       Impact factor: 6.150

Review 2.  A perspective on mesenchymal stromal cell transplantation in the treatment of sepsis.

Authors:  Nuray Kusadasi; A B Johan Groeneveld
Journal:  Shock       Date:  2013-11       Impact factor: 3.454

Review 3.  Concise review: Therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis.

Authors:  Vladislav Volarevic; Jasmin Nurkovic; Nebojsa Arsenijevic; Miodrag Stojkovic
Journal:  Stem Cells       Date:  2014-11       Impact factor: 6.277

Review 4.  Stem cell therapy to cure type 1 diabetes: from hype to hope.

Authors:  Preeti Chhabra; Kenneth L Brayman
Journal:  Stem Cells Transl Med       Date:  2013-04-09       Impact factor: 6.940

5.  Bcl-xL Genetic Modification Enhanced the Therapeutic Efficacy of Mesenchymal Stem Cell Transplantation in the Treatment of Heart Infarction.

Authors:  Xiaodong Xue; Yu Liu; Jian Zhang; Tao Liu; Zhonglu Yang; Huishan Wang
Journal:  Stem Cells Int       Date:  2015-05-05       Impact factor: 5.443

6.  Lipopolysaccharide pretreatment inhibits LPS-induced human umbilical cord mesenchymal stem cell apoptosis via upregulating the expression of cellular FLICE-inhibitory protein.

Authors:  Yu Sen Hou; Ling Ying Liu; Jia Ke Chai; Yong Hui Yu; Hong Jie Duan; Quan Hu; Hui Nan Yin; Yi He Wang; Shu Bo Zhuang; Jun Fan; Wan Li Chu; Li Ma
Journal:  Mol Med Rep       Date:  2015-05-04       Impact factor: 2.952

Review 7.  Mesenchymal stem cell therapy and acute graft-versus-host disease: a review.

Authors:  Bruna Amorin; Ana Paula Alegretti; Vanessa Valim; Annelise Pezzi; Alvaro Macedo Laureano; Maria Aparecida Lima da Silva; Andréa Wieck; Lucia Silla
Journal:  Hum Cell       Date:  2014-06-06       Impact factor: 4.174

Review 8.  Mesenchymal stem cells: mechanisms and role in bone regeneration.

Authors:  Yunhao Qin; Junjie Guan; Changqing Zhang
Journal:  Postgrad Med J       Date:  2014-11       Impact factor: 2.401

9.  Preconditioning diabetic mesenchymal stem cells with myogenic medium increases their ability to repair diabetic heart.

Authors:  Mohsin Khan; Fatima Ali; Sadia Mohsin; Shoaib Akhtar; Azra Mehmood; Mahmood S Choudhery; Shaheen N Khan; Sheikh Riazuddin
Journal:  Stem Cell Res Ther       Date:  2013-05-24       Impact factor: 6.832

Review 10.  The role of mesenchymal stem cells in cancer development.

Authors:  Hiroshi Yagi; Yuko Kitagawa
Journal:  Front Genet       Date:  2013-11-27       Impact factor: 4.599

View more
  56 in total

Review 1.  Influences of Xeno-Free Media on Mesenchymal Stem Cell Expansion for Clinical Application.

Authors:  Hue Thi Hong Bui; Liem Thanh Nguyen; Uyen Thi Trang Than
Journal:  Tissue Eng Regen Med       Date:  2020-11-04       Impact factor: 4.169

2.  Human Fallopian Tube - Derived Mesenchymal Stem Cells Inhibit Experimental Autoimmune Encephalomyelitis by Suppressing Th1/Th17 Activation and Migration to Central Nervous System.

Authors:  Carla Longo de Freitas; Carolina Manganeli Polonio; Wesley Nogueira Brandão; Cristiano Rossato; Nágela Ghabdan Zanluqui; Lilian Gomes de Oliveira; Marília Garcia de Oliveira; Lucila Pires Evangelista; Silvio Halpern; Mariangela Maluf; Carlos Eduardo Czresnia; Paulo Perin; Danilo Candido de Almeida; Jean Pierre Schatzmman Peron
Journal:  Stem Cell Rev Rep       Date:  2021-08-28       Impact factor: 5.739

Review 3.  Immunoengineering the next generation of arthritis therapies.

Authors:  Molly Klimak; Robert J Nims; Lara Pferdehirt; Kelsey H Collins; Natalia S Harasymowicz; Sara J Oswald; Lori A Setton; Farshid Guilak
Journal:  Acta Biomater       Date:  2021-04-03       Impact factor: 8.947

4.  Exosomes from IL-1β-Primed Mesenchymal Stem Cells Inhibited IL-1β- and TNF-α-Mediated Inflammatory Responses in Osteoarthritic SW982 Cells.

Authors:  Mijin Kim; Dong Il Shin; Byung Hyune Choi; Byoung-Hyun Min
Journal:  Tissue Eng Regen Med       Date:  2021-01-25       Impact factor: 4.169

5.  Gingival-Derived Mesenchymal Stem Cell from Rabbit (Oryctolagus cuniculus): Isolation, Culture, and Characterization.

Authors:  Alexander Patera Nugraha; Fedik Abdul Rantam; Ida Bagus Narmada; Diah Savitri Ernawati; Igo Syaiful Ihsan
Journal:  Eur J Dent       Date:  2020-12-01

Review 6.  New therapeutic approaches of mesenchymal stem cells-derived exosomes.

Authors:  Jana Janockova; Lucia Slovinska; Denisa Harvanova; Timea Spakova; Jan Rosocha
Journal:  J Biomed Sci       Date:  2021-05-25       Impact factor: 8.410

Review 7.  Human umbilical cord mesenchymal stem cells in type 2 diabetes mellitus: the emerging therapeutic approach.

Authors:  Andreia Gomes; Pedro Coelho; Raquel Soares; Raquel Costa
Journal:  Cell Tissue Res       Date:  2021-05-29       Impact factor: 5.249

Review 8.  Therapeutic Potential of Endothelial Progenitor Cells in Pulmonary Diseases.

Authors:  Olena A Kolesnichenko; Jeffrey A Whitsett; Tanya V Kalin; Vladimir V Kalinichenko
Journal:  Am J Respir Cell Mol Biol       Date:  2021-11       Impact factor: 6.914

Review 9.  Mesenchymal Stem Cell-Based Therapy for Diabetes Mellitus: Enhancement Strategies and Future Perspectives.

Authors:  Haisen Li; Hao Zhu; Ting Ge; Zhifeng Wang; Chao Zhang
Journal:  Stem Cell Rev Rep       Date:  2021-03-05       Impact factor: 5.739

10.  Amniotic membrane-mesenchymal stromal cells secreted factors and extracellular vesicle-miRNAs: Anti-inflammatory and regenerative features for musculoskeletal tissues.

Authors:  Enrico Ragni; Andrea Papait; Carlotta Perucca Orfei; Antonietta Rosa Silini; Alessandra Colombini; Marco Viganò; Francesca Libonati; Ornella Parolini; Laura de Girolamo
Journal:  Stem Cells Transl Med       Date:  2021-03-03       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.